Onconic Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	716,082	869,777	176,537	-	-	-
Market Cap Growth	192.52%	392.69%	-	-	-	-
Enterprise Value	658,892	816,363	152,373	-	-	-
Last Close Price	15770.00	19550.00	4085.00	-	-	-
PE Ratio	35.23	55.11	-	-	-	-
PS Ratio	10.66	16.29	11.90	-	-	-
PB Ratio	9.00	12.07	3.15	-	-	-
P/TBV Ratio	9.00	12.07	3.15	-	-	-
P/FCF Ratio	54.06	78.41	-	-	-	-
P/OCF Ratio	52.70	76.33	-	-	-	-
EV/Sales Ratio	9.80	15.29	10.27	-	-	-
EV/EBITDA Ratio	40.74	62.09	-	-	-	-
EV/EBIT Ratio	42.16	64.69	-	-	-	-
EV/FCF Ratio	49.75	73.60	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	-0.06	0.00	-0.02
Debt / EBITDA Ratio	0.01	0.01	-	0.13	-	-
Debt / FCF Ratio	0.01	0.01	-	0.12	-	-
Net Debt / Equity Ratio	-0.72	-0.73	-0.76	5.05	1.24	2.34
Net Debt / EBITDA Ratio	-3.54	-4.00	9.82	-11.05	1.85	2.25
Net Debt / FCF Ratio	-4.32	-4.74	5.35	-9.97	1.56	2.11
Asset Turnover	0.90	0.78	0.30	0.62	0.00	-
Quick Ratio	9.42	17.48	10.61	0.71	1.06	36.08
Current Ratio	9.48	17.62	10.94	0.71	1.06	36.10
Return on Equity (ROE)	29.48%	24.65%	-32.29%	-	-	-
Return on Assets (ROA)	13.01%	11.55%	-6.09%	4.07%	-36.85%	-
Return on Capital Employed (ROCE)	19.60%	17.50%	-8.50%	-39.40%	-343.70%	-44.10%
Earnings Yield	2.84%	1.81%	-4.58%	-	-	-
FCF Yield	1.85%	1.27%	-4.52%	-	-	-
Buyback Yield / Dilution	-	-38.72%	-41.46%	0.00%	-0.94%	-